Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk

por Lindmark, F, Zheng, S L, Wiklund, F, Bälter, K A, Sun, J, Chang, B, Hedelin, M, Clark, J, Johansson, J-E, Meyers, D A, Adami, H-O, Isaacs, W, Grönberg, H, Xu, J
Publicado 2005